We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2025 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Coffee, Decaffeinated Coffee, and Tea Consumption Linked to Lower Diabetes Risk

By HospiMedica International staff writers
Posted on 22 Dec 2009
High intakes of coffee, decaffeinated coffee, and tea are linked to a reduced risk of Type 2 Diabetes Mellitus, according to a pooled review of studies.

Researchers at the George Institute for International Health (Sydney, Australia), the University of Glasgow (United Kingdom), and other institutions conducted a systematic review and meta-analysis investigating the association among coffee, decaffeinated coffee, and tea consumption with the risk of diabetes mellitus. The meta-analysis included data obtained from 18 studies that reported on the association between coffee consumption and diabetes; six studies that reported estimates of the association between decaffeinated coffee and diabetes; and seven studies that reported on the association of tea.

The results of the pooled meta-analysis found that drinking coffee was inversely related to risk of diabetes (more coffee was linked to lower risk). After adjusting for potential confounders, every extra cup of coffee consumed in a day was linked to a 7% reduction in the excess risk of diabetes; drinking 3 to 4 cups per day was linked to a 25% lower risk than drinking none or up to two cups per day. In those studies that assessed decaffeinated coffee consumption, drinking more than 3 to 4 cups a day was linked to about one third lower risk of diabetes, compared to none. Drinking more than 3 to 4 cups of tea per day was linked to a one fifth lower risk of diabetes, compared to non-tea drinking. The authors suggested the effect of tea and coffee consumption on diabetes risk could be due to direct biological effects, since their apparent protective effect appears to be independent of potential confounding variables, and could partly be due to other compounds present in tea and coffee, such as magnesium, or antioxidants such as lignans or chlorogenic acids. The study was published in the December 14, 2009, issue of the Archives on Internal Medicine.

"If such beneficial effects were observed in interventional trials to be real, the implications for the millions of individuals who have diabetes mellitus, or who are at future risk of developing it, would be substantial,” concluded first author Rachel Huxley, M.D., of the George Institute, and colleagues. "It could also be envisaged that we will advise our patients most at risk for diabetes mellitus to increase their consumption of tea and coffee in addition to increasing their levels of physical activity and weight loss.”

Related Links:

George Institute for International Health
University of Glasgow


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
LED Surgical Lamp
ACEMST35/57

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more